Prof Vinciane Rebours
Gastroenterology — Beaujon Hospital, France
Vinciane Rebours
LeadR Profile
Gastroenterology
Subspecialties: Oncology - Hepatology - Surgery
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2005 - 2026
Number : 336
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Aetiology-Specific Pancreatic Enzyme Dose Requirements and Treatment Outcomes in Pancreatic Exocrine Insufficiency: The Multicentre EURO-PEI Registry. registries, pancreatic neoplasms, pancreatitis, chronic, neoplasms, signs and symptoms, pancreatitis, enzymes, therapeutics, gastrointestinal diseases, pancreatectomy | United European Gastroenterol J | 2026 | 0 |
| Clinical application of digital pathology in small intestinal neuroendocrine tumours: proposal of a new G0 category. telepathology, pathology, neoplasm metastasis | Endocr Oncol | 2026 | 0 |
| Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer. intelligence, pancreatic neoplasms, neoplasms, drug therapy, biomarkers, chemotherapy, adjuvant, deep learning, histology, therapeutics, medical oncology, learning, artificial intelligence, chemotherapy | J Clin Oncol Top journal | 2026 | 0 |
| Immune Markers and Risk of Pancreatic Cancer in the European EPIC Cohort. pancreatic neoplasms, neoplasms, interleukin-6, cohort studies, immune system | Int J Cancer | 2026 | 0 |
| French protocol for diagnosis and management (guidelines) of IgG4-related disease. glucocorticoids, laboratories, serum, fibrosis, internal medicine, immunoglobulin g4-related disease, signs and symptoms, diagnosis, therapeutics, plasma | Rev Med Interne | 2026 | 0 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| French National Cohort of Patients With PRSS1 Mutations NCT07413029 — genes, pancreatitis, history, mutation | N/A | Recruiting | 2024 |
| A Phase 3 Study of Obexelimab in Patients With IgG4 Related Disease NCT05662241 — cells, safety, immunoglobulin g4-related disease, immunoglobulins, antibodies, monoclonal, b-lymphocytes | Phase 3 | Active not recruiting | 2023 |
LeadR Networks
Main global connection map